P238 EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2− breast cancer

Autor:	P Tönnies, K. Kastrup, R Kronenwett, W Schlake, S Wilhelms, G Schlake, F Tiecke, C Petry, N. Bleuel
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty Chemotherapy Breast cancer business.industry Internal medicine medicine.medical_treatment medicine Surgery General Medicine Treatment decision making business medicine.disease
Zdroj:	The Breast. 24:S107
ISSN:	0960-9776
DOI:	10.1016/s0960-9776(15)70270-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e3ac1b9582a794f856c71ff55f939dff https://doi.org/10.1016/s0960-9776(15)70270-5 Zobrazit plný text záznamu Full Text from ScienceDirect